scispace - formally typeset
A

Alexandra Stubelius

Researcher at University of Gothenburg

Publications -  36
Citations -  963

Alexandra Stubelius is an academic researcher from University of Gothenburg. The author has contributed to research in topics: Arthritis & Estrogen. The author has an hindex of 15, co-authored 30 publications receiving 665 citations. Previous affiliations of Alexandra Stubelius include Sahlgrenska University Hospital & University of Montana.

Papers
More filters
Journal ArticleDOI

Choline Uptake and Metabolism Modulate Macrophage IL-1β and IL-18 Production.

TL;DR: It is found that Toll-like receptor (TLR) activation enhances choline uptake by macrophages and microglia through induction of the choline transporter CTL1, and choline kinase inhibitors ameliorated acute and chronic models of IL-1β-dependent inflammation.
Journal ArticleDOI

The Chemistry of Boronic Acids in Nanomaterials for Drug Delivery.

TL;DR: Both materials functionalized with BA and boronic esters display good safety profiles in vitro and in vivo; thus, BA-containing materials represent promising carriers for responsive delivery systems with great potential for clinical translation.
Journal ArticleDOI

Roles of transactivating functions 1 and 2 of estrogen receptor-α in bone

TL;DR: Estradiol treatment increased the amount of both trabecular and cortical bone in ovariectomized (OVX) WT mice and the effect of E2 in OVX ERαAF-10 mice was tissue-dependent, with no or weak E2 response on thymus and uterine weights but a normal response on liver weight.
Journal ArticleDOI

Inflammation-responsive Drug-conjugated Dextran Nanoparticles Enhance Anti-inflammatory Drug Efficacy

TL;DR: It is believed that drug conjugation using PBA can be applied to various drugs and dextran-based materials for enhanced drug efficacy, where this work demonstrates the significance of functionalized carbohydrates polymer-drug conjugates.
Journal ArticleDOI

Estrogen regulates T helper 17 phenotype and localization in experimental autoimmune arthritis.

TL;DR: E2 treatment results in an increase in Th17 cells in lymph nodes during the early phase of arthritis development, but leads to a decrease of Th17 in joints during established arthritis, suggesting that this may be caused by interference with the CCR6-CCL20 pathway, which is important for Th17 cell migration.